Identification and Characterization of Novel, Naturally Processed Measles Virus Class II HLA-DRB1 Peptides
- 1 January 2004
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 78 (1) , 42-51
- https://doi.org/10.1128/jvi.78.1.42-51.2004
Abstract
Previously, we identified a naturally processed and presented measles virus (MV) 19-amino-acid peptide, ASDVETAEGGEIHELLRLQ (MV-P), derived from the phosphoprotein and eluted from the human leukocyte antigen (HLA) class II molecule by using mass spectrometry. We report here the identification of a 14-amino-acid peptide, SAGKVSSTLASELG, derived from the MV nucleoprotein (MV-N) bound to HLA-DRB1*0301. Peripheral blood mononuclear cells (PBMC) from 281 previously vaccinated measles-mumps-rubella II (MMR-II) subjects (HLA discordant) were studied for peptide recognition by T cells. Significant gamma interferon (IFN-γ) responses to MV-P and MV-N peptides were observed in 55.9 and 15.3% of subjects, respectively. MV-P- and MV-N-specific interleukin-4 (IL-4) responses were detected in 19.2 and 23.1%, respectively, of PBMC samples. Peptide-specific cytokine responses and HLA-DRB1 allele associations revealed that, for the MV-P peptide, the allele with the strongest association with both IFN-γ (P= 0.02) and IL-4 (P= 0.03) secretion was DRB1*0301. For MV-N, the allele with the strongest association with IFN-γ secretion was DRB1*1501 (P= 0.04), and the alleles with the strongest associations with IL-4 secretion were DRB1*1103 and DRB1*1303 (P= 0.01). These results indicate that HLA class II MV proteins can be processed, presented, and identified, and the ability to generate cell-mediated immune responses can be demonstrated. This information is promising for new vaccine design strategies with peptide-based vaccines.Keywords
This publication has 48 references indexed in Scilit:
- The rationale of a peptide-conjugate vaccine against measlesVaccine, 2003
- Discordance at Human Leukocyte Antigen–DRB3 and Protection from Human Immunodeficiency Virus Type 1 TransmissionThe Journal of Infectious Diseases, 2002
- Frequency of HLA-DPB1 disparities detected by reference strand-mediated conformation analysis in HLA-A, -B, and -DRB1 matched siblingsHuman Immunology, 2002
- A single naturally processed measles virus peptide fully dominates the HLA-A*0201-associated peptide display and is mutated at its anchor position in persistent viral strainsEuropean Journal of Immunology, 2000
- Comparison of sequences of the H, F, and N coding genes of measles virus vaccine strainsVirus Research, 1994
- Changes in Cytokine Production after Measles Virus Vaccination: Predominant Production of IL-4 Suggests Induction of a Th2 ResponseClinical Immunology and Immunopathology, 1993
- Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cellsEuropean Journal of Immunology, 1989
- A malaria T-cell epitope recognized in association with most mouse and human MHC class II moleculesNature, 1988
- Recognition of Intracellular Measles Virus Antigens by HLA Class II Restricted Measles Virus‐Specific Cytotoxic T LymphocytesAnnals of the New York Academy of Sciences, 1988
- Persistence of maternal antibody in infants beyond 12 months: Mechanism of measles vaccine failureThe Journal of Pediatrics, 1977